Cargando…

Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc

BACKGROUND: Ovarian cancer is one of the most significant malignancies in the western world. Studies showed that Ovarian cancers tend to grow resistance to cisplatin treatment. Therefore, new approaches are needed in ovarian cancer treatment. Kaempferol is a dietary flavonoid that is widely distribu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Haitao, Daddysman, Matthew K, Rankin, Gary O, Jiang, Bing-Hua, Chen, Yi C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Primary research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885998/ https://www.ncbi.nlm.nih.gov/pubmed/20459793 http://dx.doi.org/10.1186/1475-2867-10-16

Ejemplares similares

A proteomic study of cMyc improvement of CHO culture
por: Kuystermans, Darrin, et al.
Publicado: (2010)

Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts
por: Heffernan, Corey, et al.
Publicado: (2012)

The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
por: Xu, Lei, et al.
Publicado: (2019)

Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD
por: Nishimoto, Masazumi, et al.
Publicado: (2019)

Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer
por: Zhu, Hongwen, et al.
Publicado: (2023)

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of cMYC oncoprotein
por: Geng, Chuandong, et al.
Publicado: (2017)

Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability
por: Luo, Haitao, et al.
Publicado: (2012)

Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma
por: Lin, Yun Hsiao, et al.
Publicado: (2021)

Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8
por: Anderson, David A., et al.
Publicado: (2021)

Convergence of cMyc and β‐catenin on Tcf7l1 enables endoderm specification
por: Morrison, Gillian, et al.
Publicado: (2015)

cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis
por: Sakr, Hany I., et al.
Publicado: (2017)

The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc()()
por: Prensner, John R., et al.
Publicado: (2014)

Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
por: Zhu, Jian, et al.
Publicado: (2019)

Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
por: Loftus, Róisín M., et al.
Publicado: (2018)

PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
por: Qin, Yi, et al.
Publicado: (2019)

MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
por: Chen, Pan, et al.
Publicado: (2016)

TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling
por: Song, Yuequn, et al.
Publicado: (2021)

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023)

Association of CMYC polymorphisms with hepatoblastoma risk
por: Yang, Tianyou, et al.
Publicado: (2020)

AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development
por: Takizawa, Makiko, et al.
Publicado: (2008)

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis
por: Figueiredo, Jane C, et al.
Publicado: (2007)

cMyc increases cell number through uncoupling of cell division from cell size in CHO cells
por: Kuystermans, Darrin, et al.
Publicado: (2009)

Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
por: Guo, Hua, et al.
Publicado: (2019)

The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells
por: Ye, Ling-Yun, et al.
Publicado: (2017)

Sequence-to-expression approach to identify etiological non-coding DNA variations in P53 and cMYC-driven diseases
por: Kin, Katherine, et al.
Publicado: (2023)

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
por: Freeburg, Elizabeth M, et al.
Publicado: (2009)

Down regulation of G protein-coupled receptor 137 expression inhibits proliferation and promotes apoptosis in leukemia cells
por: Men, Li-Jie, et al.
Publicado: (2018)

Kaempferol Induces G2/M Cell Cycle Arrest via Checkpoint Kinase 2 and Promotes Apoptosis via Death Receptors in Human Ovarian Carcinoma A2780/CP70 Cells
por: Gao, Ying, et al.
Publicado: (2018)

Sevoflurane inhibits the progression of ovarian cancer through down-regulating stanniocalcin 1 (STC1)
por: Zhang, Chuanfeng, et al.
Publicado: (2019)

Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming
por: Simula, Luca, et al.
Publicado: (2018)

Down-regulation of cylindromatosis protein phosphorylation by BTK inhibitor promotes apoptosis of non-GCB-diffuse large B-cell lymphoma
por: Xu, Xin, et al.
Publicado: (2021)

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
por: Schmidtova, Silvia, et al.
Publicado: (2020)

Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway
por: Wang, Shuang, et al.
Publicado: (2020)

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
por: Zhou, Yang, et al.
Publicado: (2022)

Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway
por: Liao, Xiao-Zhong, et al.
Publicado: (2017)

Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation
por: Henes, Melanie, et al.
Publicado: (2018)

cMyc/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas
por: Manfè, Valentina, et al.
Publicado: (2013)

RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
por: George, Jasmine, et al.
Publicado: (2021)

Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma
por: Jiang, Houxiang, et al.
Publicado: (2023)

The Evi5 oncogene promotes laryngeal cancer cells proliferation by stabilizing c-Myc protein
por: Mao, Cheng-Gang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_61psnhf0caor36f1f5rej5ao7l